Oct 14 (Reuters) - enGene Inc says:
* Engene announces strategic collaboration with Johnson & Johnson (N:JNJ) innovation to
develop novel gene delivery products for inflammatory bowel disease
* Engene inc says engene will receive an upfront payment, equity investment
through Johnson & Johnson innovation - jjdc, inc. and research and
development funding
* Engene inc says engene is eligible to receive various milestone payments up
to a total of C$441 million
* Engene inc says engene also eligible to receive tiered royalties on potential net sales of products
* Source text for Eikon ID:nPn1yKGQw
* Further company coverage JNJ.N